| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/07/2004 | CN1156282C 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 07/07/2004 | CN1156279C Mometasone furoate as nasal spray and its preparing process |
| 07/07/2004 | CN1156277C Rapidlly soluble drug composition |
| 07/07/2004 | CN1156274C Medicinal ointment containing zinc conjugated linoleate and sodium humate |
| 07/07/2004 | CN1156273C Far infrared nano plaster |
| 07/07/2004 | CN1156272C Plaster with magnetic field effect |
| 07/07/2004 | CN1156271C Macromolecular coating powder for solid medicine preparation and its preparation method |
| 07/07/2004 | CN1156270C Method for producing solid dosing forms |
| 07/07/2004 | CN1156269C Liposome composition having resistance to freeze/thaw damage |
| 07/06/2004 | US6759436 Clear micellized formulations of β-carotene and method of treating leukoplakia |
| 07/06/2004 | US6759434 Anti-infective compositions, methods and systems for treating disordered tissue |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759398 Anti-inflammatory androstane derivative |
| 07/06/2004 | US6759395 Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same |
| 07/06/2004 | US6759064 Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer |
| 07/06/2004 | US6759060 Encapsulation |
| 07/06/2004 | US6759059 Fentanyl composition for the treatment of acute pain |
| 07/06/2004 | US6759058 Enteric-coated proliposomal formulations for poorly water soluble drugs |
| 07/06/2004 | US6759057 Glycolipids such as galactolipids including digalactosyl diglyceride |
| 07/06/2004 | US6759056 For therapeutic and cosmetic application |
| 07/06/2004 | US6759051 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol |
| 07/06/2004 | US6759050 Stable; recombinant adeno-associated virus (raav) virions that provide protection against loss of transduceability due to manipulation, storage, transport; a dihydric or polyhydric alcohol; polyethylene glycol, propylene glycol, sorbitol |
| 07/06/2004 | US6759029 Aerosols |
| 07/06/2004 | US6758840 Drug delivery device |
| 07/06/2004 | US6758810 Ambulatory medical apparatus and method using a robust communication protocol |
| 07/06/2004 | US6758161 Device for the coating of granulates and seeds |
| 07/06/2004 | CA2433080C Stable enzymatic wound debrider |
| 07/06/2004 | CA2278759C Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 07/06/2004 | CA2251816C Sustained release heterodisperse hydrogel systems - amorphous drugs |
| 07/01/2004 | WO2004055260A1 Use of multimolecular layers to reduce evaporation of water |
| 07/01/2004 | WO2004055164A2 System and method for stabilizing antibodies with histidine |
| 07/01/2004 | WO2004054904A1 Extendable belt conveyor |
| 07/01/2004 | WO2004054702A1 Complex coacervate encapsulate comprising lipophilic core |
| 07/01/2004 | WO2004054638A2 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 07/01/2004 | WO2004054637A2 Contrast media formulations having improved biological tolerance |
| 07/01/2004 | WO2004054620A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent |
| 07/01/2004 | WO2004054619A1 Light-blocking agent and film-forming composition |
| 07/01/2004 | WO2004054609A1 Placental alkaline phosphatase to control diabetes |
| 07/01/2004 | WO2004054606A1 Method of decreasing hepatic glucose output in diabetic patients |
| 07/01/2004 | WO2004054605A1 Freeze-dried interferon-ϝ composition for transpulmonary administration and inhalation system therefor |
| 07/01/2004 | WO2004054602A1 Orally administerable protein preparation and method of orally administering the same |
| 07/01/2004 | WO2004054600A1 Pharmaceutical compound containing silymarin and carbopol®, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 07/01/2004 | WO2004054589A1 Intravitreally-injectable solution for the treatment of vitreous haemorrhages |
| 07/01/2004 | WO2004054580A1 Tiotropium containing hfc solution formulations |
| 07/01/2004 | WO2004054576A1 Pharmaceutical compositions of sertaconazole for vaginal use |
| 07/01/2004 | WO2004054574A1 Solid drug for oral use |
| 07/01/2004 | WO2004054571A1 Controlled release preparations comprising tramadol and topiramate |
| 07/01/2004 | WO2004054568A1 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
| 07/01/2004 | WO2004054562A1 Method for preventing abuse of methylphenidate |
| 07/01/2004 | WO2004054556A1 Pharmaceutical porous particles |
| 07/01/2004 | WO2004054555A1 Novel dry powder inhalation system for transpulmonary administration |
| 07/01/2004 | WO2004054554A1 Transdermal buprenorphine to treat pain in sickle cell crisis |
| 07/01/2004 | WO2004054553A1 Transdermal buprenorphine dosage regimen for analgesia |
| 07/01/2004 | WO2004054552A1 Transdermal composition of an antivomiting agent |
| 07/01/2004 | WO2004054551A1 Film-type preparations for transmucosal administration of nicotine and method for the production thereof |
| 07/01/2004 | WO2004054550A1 An extended release pharmaceutical composition of phenytoin sodium |
| 07/01/2004 | WO2004054549A1 A topical nanoparticulate spironolactone formulation |
| 07/01/2004 | WO2004054547A1 Stable topiramate formulations |
| 07/01/2004 | WO2004054546A1 Formulation for fast dissolution of lipophilic compounds |
| 07/01/2004 | WO2004054545A1 Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation |
| 07/01/2004 | WO2004054544A1 Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof |
| 07/01/2004 | WO2004054543A1 Process for the chemical stabilization of a solubilized retinoid in a solvent using a base |
| 07/01/2004 | WO2004054542A2 Oral drug delivery system comprising high viscosity liquid carrier materials |
| 07/01/2004 | WO2004054541A2 Ketoprofen compositions and methods of making them |
| 07/01/2004 | WO2004054540A2 Solid compositions with improved bio-availability of insoluble or poorly water soluble drugs and a corresponding process for preparing such |
| 07/01/2004 | WO2004054539A1 Medicinal compositions comprising a core and a film based on modified cellulose derivatives |
| 07/01/2004 | WO2004054538A1 Mastitis treatment |
| 07/01/2004 | WO2004054500A2 Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole |
| 07/01/2004 | WO2004054499A2 Platinum aggregates and process for producing the same |
| 07/01/2004 | WO2004054356A2 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 07/01/2004 | WO2004047673A3 Treatment of liver disease with active vitamin d compounds |
| 07/01/2004 | WO2004041241A3 Implantable structure for prolonged and controlled release of an active principle |
| 07/01/2004 | WO2004032909A3 Stabilized pharmaceutical composition containing basic excipients |
| 07/01/2004 | WO2004032862A3 Cyclodextrin-based materials, compositions and uses related thereto |
| 07/01/2004 | WO2004031581A3 Electroactive polymer actuated medication infusion pumps |
| 07/01/2004 | WO2004026950A3 Solid flowable powder with high liquid loading |
| 07/01/2004 | WO2004026256A3 Sustained-release opioid formulations and methods of use |
| 07/01/2004 | WO2004019892A3 Drug delivery system for treating urinary incontinence |
| 07/01/2004 | WO2004019865A3 Amelioration of effects of cigarette smoke |
| 07/01/2004 | WO2004012855A3 Ethylene glycol monolayer protected nanoparticles |
| 07/01/2004 | WO2004010894A3 Ophthalmologic irrigation solutions and method |
| 07/01/2004 | WO2004004635A3 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 07/01/2004 | WO2003082193A3 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 07/01/2004 | WO2003053445A8 Use of desoxypeganine for treating clinical depression |
| 07/01/2004 | WO2003053221A3 Methods using proton pump inhibitors |
| 07/01/2004 | WO2003051278A3 Nanoparticle delivery vehicle |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | US20040127844 Flow condition sensor assembly for patient infusion device |
| 07/01/2004 | US20040127826 Honey in wound dressings |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127580 Emulsions including surface-modified inorganic nanoparticles |
| 07/01/2004 | US20040127578 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 07/01/2004 | US20040127566 all-trans retinoic acid (inter alia, liposomal all-trans retinoic acid) of at least about 10 mg at least about every other day |
| 07/01/2004 | US20040127557 liquid preparations of oxaliplatin, ready to be administered parenterally by infusion; concentration of at least 7 mg/ml; solvent is one hydroxylated derivative chosen from 1,2-propanediol, glycerol, maltitol, sucrose and inositol |
| 07/01/2004 | US20040127541 Bicifadine formulation |
| 07/01/2004 | US20040127537 Stable liquid parenteral parecoxib formulation |
| 07/01/2004 | US20040127531 backing sheet that is flexibly conformable to the area of skin coated on the proximal surface of thereof with an adhesive and an active agent comprising valdecoxib or a prodrug thereof or a salt thereof |
| 07/01/2004 | US20040127490 Administering a therapeutic amount of an alprazolam, estazolam, midazolam or triazolam condensation aerosol for therapy of anxiety or insomnia |
| 07/01/2004 | US20040127481 Administering a therapeutic amount of a lidocaine, verapamil, diltiazem, isometheptene, or lisuride condensation aerosol |
| 07/01/2004 | US20040127476 For human and veterinary applications |